slotkoers
Korea S.E.
00:00:00 21-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
14.010
KRW
|
-1,48%
|
|
+8,35%
|
+32,80%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
71.577
|
79.626
|
309.325
|
249.696
|
212.385
|
233.123
|
Bedrijfswaarde
1 |
61.535
|
85.731
|
284.800
|
235.379
|
183.323
|
210.837
|
K/w-verhouding
|
-5,89
x
|
-14,8
x
|
-9,87
x
|
-72,3
x
|
-13,1
x
|
-34,7
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
12,7
x
|
9,75
x
|
28,1
x
|
21,1
x
|
16,9
x
|
16,7
x
|
Bedrijfswaarde/omzet
|
10,9
x
|
10,5
x
|
25,9
x
|
19,9
x
|
14,6
x
|
15,1
x
|
Bedrijfswaarde/EBITDA
|
-12
x
|
-42,3
x
|
-340
x
|
-70,9
x
|
-22
x
|
-76,6
x
|
Bedrijfswaarde/FCF
|
41,2
x
|
-7,33
x
|
-68,2
x
|
-10,6
x
|
-25
x
|
-29,2
x
|
FCF Yield
|
2,43%
|
-13,6%
|
-1,47%
|
-9,42%
|
-4,01%
|
-3,43%
|
Price to Book
|
4,35
x
|
7,13
x
|
7,32
x
|
4,74
x
|
3,03
x
|
3,66
x
|
Aantal aandelen (in duizenden)
|
8.969
|
8.969
|
16.447
|
17.738
|
22.100
|
22.097
|
Referentieprijs
2 |
7.981
|
8.878
|
18.808
|
14.077
|
9.610
|
10.550
|
Datum van publicatie
|
15-03-19
|
11-03-20
|
19-03-21
|
18-03-22
|
20-03-23
|
13-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
5.635
|
8.167
|
11.013
|
11.818
|
12.574
|
13.968
|
EBITDA
1 |
-5.113
|
-2.026
|
-837,1
|
-3.322
|
-8.323
|
-2.752
|
Bedrijfsresultaat (EBIT)
1 |
-7.286
|
-5.367
|
-4.921
|
-7.894
|
-12.932
|
-8.408
|
Operationele Marge
|
-129,29%
|
-65,72%
|
-44,68%
|
-66,8%
|
-102,85%
|
-60,19%
|
Resultaat voor belastingen (EBT)
1 |
-12.080
|
-5.490
|
-23.194
|
-3.464
|
-14.007
|
-6.701
|
Nettowinst (verlies)
1 |
-11.969
|
-5.368
|
-23.101
|
-3.420
|
-13.959
|
-6.709
|
Nettomarge
|
-212,38%
|
-65,73%
|
-209,76%
|
-28,93%
|
-111,02%
|
-48,03%
|
WPA
2 |
-1.354
|
-598,5
|
-1.906
|
-194,6
|
-732,0
|
-304,0
|
Free Cash Flow
1 |
1.492
|
-11.701
|
-4.179
|
-22.182
|
-7.347
|
-7.231
|
FCF-marge
|
26,48%
|
-143,28%
|
-37,94%
|
-187,69%
|
-58,43%
|
-51,77%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
15-03-19
|
11-03-20
|
19-03-21
|
18-03-22
|
20-03-23
|
13-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
6.105
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
10.042
|
-
|
24.525
|
14.318
|
29.062
|
22.286
|
Hefboom (schuld/ebitda)
|
-
|
-3,013
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1.492
|
-11.701
|
-4.179
|
-22.182
|
-7.347
|
-7.231
|
ROE (netto-inkomsten/eigen vermogen)
|
-54,8%
|
-38,7%
|
-84,2%
|
-7,18%
|
-22,7%
|
-10%
|
ROA (netto-inkomsten/totale activa)
|
-9,1%
|
-5,27%
|
-4,22%
|
-6,18%
|
-9,75%
|
-6,51%
|
Totale activa
1 |
131.479
|
101.831
|
547.096
|
55.305
|
143.227
|
103.126
|
Nettoactief per aandeel
2 |
1.835
|
1.245
|
2.570
|
2.972
|
3.174
|
2.886
|
Cashflow per aandeel
2 |
697,0
|
285,0
|
228,0
|
199,0
|
144,0
|
390,0
|
Capex
1 |
8.342
|
6.933
|
3.438
|
8.391
|
2.987
|
3.569
|
Capex/omzet
|
148,02%
|
84,9%
|
31,21%
|
71%
|
23,76%
|
25,55%
|
Datum van publicatie
|
15-03-19
|
11-03-20
|
19-03-21
|
18-03-22
|
20-03-23
|
13-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +32,80% | 231 mln. | | -6,26% | 12,23 mld. | | -3,93% | 8,17 mld. | | +7,10% | 5,78 mld. | | +30,16% | 5,74 mld. | | -7,47% | 4,24 mld. | | -57,20% | 2,97 mld. | | +12,56% | 2,73 mld. | | -4,67% | 2,38 mld. | | +27,38% | 2,26 mld. |
Diagnostische en teststoffen
|